GC Biopharma Secures IND Approval for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea
– Phase 2 IND submission targeted for the second half of 2026– Demonstrating the competitiveness of GC Biopharma’s mRNA platform YONGIN, South... Read more.
Harris Cyber Policy Initiative Taps Top Hacker to Design New Security Model for Water Utilities
Senior Fellow appointment advances first-of-its-kind managed security solution for rural and underserved systems CHICAGO, Dec. 22, 2025 /PRNewswire/ — The... Read more.
LG Display unveils world’s first 240Hz RGB stripe OLED panel
SEOUL, South Korea, Dec. 22, 2025 /PRNewswire/ — LG Display, the world’s leading innovator of display technologies, announced today that it will debut... Read more.
Toppan Merrill announces new Quinn platform to broad market acceptance
Consultative technology leader backed by 55+ years of industry and service expertise NEW YORK and ST. PAUL, Minn., Dec. 22, 2025 /PRNewswire/ — Toppan Merrill,... Read more.
MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi
KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ — MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat (KPSIAJ) announced the signing of a landmark... Read more.
Warner Bros. Discovery Confirms Receipt of Amended, Unsolicited Tender Offer from Paramount Skydance
NEW YORK, Dec. 22, 2025 /PRNewswire/ — Warner Bros. Discovery, Inc. (“Warner Bros. Discovery” or “WBD”) (NASDAQ: WBD) today confirmed... Read more.
FINALS, SEMI-FINALS AND NON-STOP ACTION AS GOTF 2025 REACHES CLIMAX
On the penultimate day of competition, teams across various disciplines battled for a place in the finals, while Phygital Drone Racing produced a worthy winner.... Read more.
Huntington Bancshares Incorporated and Cadence Bank Announce Receipt of Required Regulatory Approval for Pending Merger
COLUMBUS, Ohio and HOUSTON and TUPELO, Miss., Dec. 22, 2025 /PRNewswire/ — Huntington Bancshares Incorporated (Nasdaq: HBAN); (“Huntington”) and... Read more.
Paranovus Entertainment Technology Limited Received Nasdaq Delisting Notice
NEW YORK, Dec. 22, 2025 /PRNewswire/ — Paranovus Entertainment Technology Limited (NASDAQ: PAVS), announced today that the Company received a letter from the... Read more.
Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy
SAN DIEGO, Dec. 22, 2025 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy,... Read more.